세포배양 비타민 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Cell Culture Vitamins Market Growth & Trends:

The global cell culture vitamins market size is expected to reach USD 343.0 million by 2030 and is expected to grow at 5.6% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has experienced considerable growth as there is an increase in reliance on cell culture technologies across various sectors, particularly in biopharmaceutical research and development

One of the key drivers propelling the growth of the cell culture vitamins market is the significant rise in research and development (R&D) investments across the biotechnology and pharmaceutical sectors. Governments, private organizations, and academic institutions increasingly allocate funds to support innovative drug development, vaccine research, and advanced therapeutic techniques such as gene and cell therapies.

The COVID-19 pandemic has had a profound impact on the cell culture vitamins market. The urgent need for vaccines and biologics accelerated demand for high-quality, scalable cell culture supplements, including vitamins, which are critical in ensuring rapid and consistent production, supporting research, and enabling efficient manufacturing processes to meet global vaccine demand. This surge in demand underscored the importance of cell culture media formulations in vaccine and therapeutic development. Consequently, the pandemic not only amplified the immediate need for cell culture vitamins but also highlighted their essential role in biopharmaceutical manufacturing, thereby reinforcing the market's growth trajectory

The rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, has significantly increased the demand for more advanced and targeted healthcare solutions. As traditional treatments often fall short in addressing complex and long-term conditions, there is a growing shift toward innovative biologics and cell-based therapies that offer more personalized and effective approaches. These advanced therapies rely heavily on cell culture technologies, where maintaining healthy and functional cells is critical for success. To achieve this, precisely controlled, nutrient-rich culture environments become essential, particularly those enriched with vitamins that support cell growth, differentiation, and immune response.

Cell Culture Vitamins Market Report Highlights:

• Based on product, the vitamin B complex segment accounted for the largest revenue share of 39.12% in 2024. The market is driven by increasing demand for high-quality cell culture media in biopharmaceutical manufacturing and research applications.
• Based on end use, the cell culture media manufacturers segment dominated the market and accounted for the largest revenue share in 2024. Growing needs from biopharmaceutical firms and research centers for premium, vitamin-rich culture media, essential for mass production of biologics, vaccines, and cell therapies, are fueling this market segment's expansion.
• North America held the largest share of 37.49% in 2024. North America has a high demand for cell culture vitamins because it leads in biotechnology, medicine, and drug development. The region is home to top research centers and companies that create vaccines, antibody treatments, and cell therapies, all of which need high-quality, vitamin-rich culture media to grow cells effectively.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End use
• 1.3. Research Methodology
• 1.4. Information Procurement
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Cell Culture Vitamins Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising demand for biopharmaceuticals
    • 3.2.1.2. Growing investment in R&D
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Stringent regulatory requirements
• 3.3. Cell Culture Vitamins Market Analysis Tools
  • 3.3.1. Porter's Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cell Culture Vitamins Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Cell Culture Vitamins Market Product Movement Analysis
• 4.3. Global Cell Culture Vitamins Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Cell Culture Vitamins
  • 4.4.1. Cell Culture Vitamins Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 4.5. Cell Culture Vitamins
  • 4.5.1. Cell Culture Vitamins Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. Cell Culture Vitamins Market: End Use Estimates & Trend Analysis

• 5.1. End Use Segment Dashboard
• 5.2. Global Cell Culture Vitamins Market End Use Movement Analysis
• 5.3. Global Cell Culture Vitamins Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Cell Culture Media Manufacturers
  • 5.4.1. Cell Culture Media Manufacturers Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.5. Pharmaceutical & Biotechnology Companies
  • 5.5.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
• 5.6. CDMOs/ CMOs & CROs
  • 5.6.1. CDMOs/ CMOs & CROs Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. Cell Culture Vitamins Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. North America
  • 6.3.1. U.S.
    • 6.3.1.1. Key country dynamics
    • 6.3.1.2. Regulatory framework
    • 6.3.1.3. Competitive scenario
    • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Canada
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Mexico
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. UK
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. France
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Italy
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Spain
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Norway
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.8. Denmark
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Japan
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Australia
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Brazil
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Argentina
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. DSM-Firmenich
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Merck KGaA
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Thermo Fisher Scientific
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. FUJIFILM Irvine Scientific
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Lonza
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. HiMedia Laboratories
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Danaher
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Sartorius AG
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Corning Inc.
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. R&D Systems (Bio-Techne)
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives